MedTrace Logo

A Clinical Trial to Assess the Efficacy and Tolerance of a Berberine-based Nutraceutical Formula to Aid Blood Sugar Regulation and Metabolism

NCT06700915 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 80

Last updated 2024-12-13

No results posted yet for this study

Summary

This randomized, triple-blind, placebo-controlled study will evaluate the efficacy of Diaberine, a berberine-based nutraceutical, in aiding blood sugar regulation and metabolism in 80 participants over 24 weeks.

Conditions

  • Metabolism Disorder
  • Nutraceutical

Interventions

DIETARY_SUPPLEMENT

Diaberine

Participants will take one capsule three times daily, 15 minutes prior to meals, over a 24-week period.

DIETARY_SUPPLEMENT

Placebo Capsule

Participants will take one capsule three times daily, 15 minutes prior to meals, over a 24-week period.

Sponsors & Collaborators

  • Citruslabs

    collaborator INDUSTRY

  • Ultimate International, Inc.

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-10-03
Primary Completion
2025-05-01
Completion
2025-05-01

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06700915 on ClinicalTrials.gov